ISPE membership engagement in PDS
Pharmacoepidemiology & Drug Safety is ISPE’s official journal, and many ISPE members actively serve on its editorial board. Recently, Wiley, the publisher of Pharmacoepidemiology & Drug Safety, agreed to waive the ISPE member access fee for the years 2025, 2026, and 2027—a generous arrangement that greatly benefits the Society and its members.
In return for this waiver, ISPE has agreed to support the journal by encouraging ISPE members, and FISPEs in particular, to participate in the journal’s pool of potential peer reviewers.
We are confident that the ISPE membership recognizes Wiley’s generosity and will respond positively to invitations to serve as reviewers for Pharmacoepidemiology & Drug Safety.
This initiative also represents an excellent opportunity for members to contribute directly to ISPE’s mission to “advance the health of the public by providing a global forum for the open exchange of scientific information and for the development of policy, education, and advocacy for the field of pharmacoepidemiology.”
Thank you all for actively contributing!
Ursula Kirchmayer, President and Jennifer Christian, VP Finance
